Repository logo
 
Publication

Use of Etonogestrel Implant Beyond Approved Duration – A Case Report

dc.contributor.authorCastro Carvalho, C
dc.contributor.authorSilveira Reis, I
dc.contributor.authorMachado, AI
dc.date.accessioned2022-07-29T14:55:15Z
dc.date.available2022-07-29T14:55:15Z
dc.date.issued2022
dc.description.abstractThe contraceptive implant is the most effective method of reversible contraception. Observational and trial data indicate that this method remains effective beyond the initially approved duration of use. We report a case of etonogestrel serum levels above the supposed threshold value for ovulation suppression nine years after implant insertion.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationActa Obstet Ginecol Port 2022;16(2):163-165pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4174
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherFederação das Sociedades Portuguesas de Obstetrícia e Ginecologiapt_PT
dc.subjectEtonogestrel implantpt_PT
dc.subjectContraceptive effectivenesspt_PT
dc.subjectNexplanon®pt_PT
dc.subjectImplanon NXT®pt_PT
dc.subjectFamily planningpt_PT
dc.subjectMAC GINpt_PT
dc.titleUse of Etonogestrel Implant Beyond Approved Duration – A Case Reportpt_PT
dc.title.alternativeUso do Implante de Etonogestrel Além da Duração Aprovada – Um Caso Clínicopt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage165pt_PT
oaire.citation.issue2pt_PT
oaire.citation.startPage163pt_PT
oaire.citation.volume16pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Acta Obstet Ginecol Port 2022_163.pdf
Size:
112.22 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections